Whole Cell Therapeutic Vaccine Modified With Hyper-IL6 for Combinational Treatment of Nonresected Advanced Melanoma-Reference-Cited by-同舟云学术

Whole Cell Therapeutic Vaccine Modified With Hyper-IL6 for Combinational Treatment of Nonresected Advanced Melanoma

Published:2015-05 Issue:21 Volume:94 Page:e853
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Mackiewicz Jacek,Karczewska-Dzionk Aldona,Laciak Maria,Kapcinska Malgorzata,Wiznerowicz Maciej,Burzykowski Tomasz,Zakowska Monika,Rose-John Stefan,Mackiewicz Andrzej

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference26 articles.

1. New targeted therapies in the treatment of patients with metastatic melanoma.;Mackiewicz;Contemp Oncol,2010

2. Gene modified cellular vaccines: technological aspects and clinical problems.;Mackiewicz;Transplantation Proc,2010

3. Immunotherapy of cancer and perspectives of its development.;Mackiewicz;Contemp Oncol,2010

4. Whats new in the treatment of advanced melanoma State of the art.;Mackiewicz;Contemp Oncol,2012

5. Immunotargeting of cancer stem cells.;Kwiatkowska-Borowczyk;Contemp Oncol,2015

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGR3 Inhibits Tumor Progression by Inducing Schwann Cell‐Like Differentiation;Advanced Science;2024-07-07

2. Utility of cell-based vaccines as cancer therapy: Systematic review and meta-analysis;Human Vaccines & Immunotherapeutics;2024-03-27

3. Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti–PD-1 Therapy;Cancer Immunology Research;2024-02-05

4. Cancer Vaccine Therapeutics: Limitations and Effectiveness—A Literature Review;Cells;2023-08-28

5. Regression of Breast Cancer Metastases Following Treatment with Irradiated SV-BR-1-GM, a GM-CSF Overexpressing Breast Cancer Cell Line: Intellectual Property and Immune Markers of Response;Recent Patents on Anti-Cancer Drug Discovery;2023-05